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Abstract
Background: Transduction of sound in the cochlea is metabolically demanding. The lateral wall and hair cells are critically
vulnerable to hypoxia, especially at high sound levels, and tight control over cochlear blood flow (CBF) is a physiological
necessity. Yet despite the importance of CBF for hearing, consensus on what mechanisms are involved has not been
obtained.
Methodology/Principal Findings: We report on a local control mechanism for regulating inner ear blood flow involving
fibrocyte signaling. Fibrocytes in the super-strial region are spatially distributed near pre-capillaries of the spiral ligament of
the albino guinea pig cochlear lateral wall, as demonstrably shown in transmission electron microscope and confocal
images. Immunohistochemical techniques reveal the inter-connected fibrocytes to be positive for Na+/K+ ATPase b1 and
S100. The connected fibrocytes display more Ca
2+ signaling than other cells in the cochlear lateral wall as indicated by
fluorescence of a Ca
2+ sensor, fluo-4. Elevation of Ca
2+ in fibrocytes, induced by photolytic uncaging of the divalent ion
chelator o-nitrophenyl EGTA, results in propagation of a Ca
2+ signal to neighboring vascular cells and vasodilation in
capillaries. Of more physiological significance, fibrocyte to vascular cell coupled signaling was found to mediate the sound
stimulated increase in cochlear blood flow (CBF). Cyclooxygenase-1 (COX-1) was required for capillary dilation.
Conclusions/Significance: The findings provide the first evidence that signaling between fibrocytes and vascular cells
modulates CBF and is a key mechanism for meeting the cellular metabolic demand of increased sound activity.
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Introduction
Sound stimulation applied to the inner ear imposes an energy
demand that requires delivery of oxygen and glucose, a demand that
requires a well-regulated cochlear blood flow (CBF) to provide both
substrate and efficacious clearance of metabolic products. While
decades of studies from different laboratories have shown that
moderatesoundactivitysignificantlyincreasesredbloodcellvelocity,
dilates vessels, and decreases local oxygen pressure [1,2,3,4], the
underlying physiological mechanisms remain undefined.
Regulation of CBF, under the prevailing model, is hypothesized
to include both local auto-regulation and central control via
neuronal pathways. In particular, CBF is thought to be mainly
regulated in the end arterial system of the cochlea, specifically in
the spiral modiolar artery and its branching arterioles [5,6]. The
model incorporates neural- and autocrine/paracrine-based regu-
lation of vasoconstriction and dilation at the level of the artery and
arterioles [5,7]. Capillary-mediated local control of perfusion has
been less studied. Our recent findings showing that cochlear
capillaries are densely populated by pericytes expressing contrac-
tile proteins [8] and exhibiting vasocontractility [9] reopens the
question about the role of capillary-based local blood-flow control.
The cochlea has two microvessel networks: the capillaries of the
stria vascularis and spiral ligament [10]. Both capillary networks
are located in the cochlear lateral wall, anatomically distant
(.100 micrometers) from sensory hair cells in the organ of Corti,
an arrangement that minimizes the effect of perturbations in blood
flow on hearing. The capillaries of the spiral ligament are arterio-
venular anastomosing vessels, passing directly across the ligament.
Preliminary studies suggest that regulation of the CBF is
dominated by this system [11]. In contrast, the capillaries of the
stria vascularis form a blood-labyrinth barrier that is critical for
maintaining endocochlear potential (EP), ion transport, and fluid
balance in the inner ear [12,13,14]. The EP is necessary for
sensory hair cell transduction.
Regulatory vessels of the spiral ligament are surrounded by five
types of fibrocytes (I–V), categorized on the basis of morphological
appearance, immunostaining pattern, and general location (see
Fig. S1) [15,16,17]. Since fibrocytes participate in ion transport
and facilitate generation of the EP by recycling K
+ from hair cells
to intermediate cells in the stria vascularis through gap junctions
[13,18,19], increased hair-cell activity must be matched by
increased fibrocyte metabolism. In brain and retina, similar cells
(astrocytes and glial cells) couple with vessels to exert direct and
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controlled by an analogous mechanism?
Thisstudyisthe firstone toshow that fibrocytesinthe super-strial
region are physically linked to vessels in the spiral ligament through
extending processes. Elevation of Ca
2+ in fibrocytes, induced by
photolytic release of caged Ca
2+, results in propagation of a Ca
2+
signal in neighboring vascular cells. Ca
2+-dependent release of a
vasoactive compound, COX-1, causes capillary dilation, and both
inhibition of COX1 and blockage of gap junctions attenuate
acoustic-evoked vasoactivity. Our findings demonstrate the key role
of fibrocyte–to-vascular cell signaled regulation of cochlear blood
flow, particularly for meeting metabolic demand during increased
sound activity. The experimental evidence supports a paradigmatic
shift in which local regulation of cochlear blood flow has a larger
role.
Materials and Methods
Ethics Statement
All procedures were reviewed and approved by the Institutional
Animal Care and Use Committee at Oregon Health & Science
University (IACUC approval number: B11265).
Animals
Albino guinea pigs (CRL: Duncan-Hartley, both sexes, age 4–5
weeks, weight 300–450 g) were used in this study.
Isolation of Whole Mounted Cochlear Lateral Wall Tissue
Guinea pigs were anesthetized with a 1 ml/kg intramuscular
injection of ketamine 500 mg, xylazine 20 mg, and acepromazine
10 mg in 8.5 mL H2O, and then sacrificed by exsanguination.
Both bullae were rapidly removed and transferred to a Petri dish
filled with a physiological solution (in mM) of NaCl 125, KCl 3.5,
glucose 5, HEPES 10, CaCl2 1.3, MgCl2 1.5, and NaH2PO4 0.51
bubbled with 95% O2 and 5% CO2. The osmolarity of the
solution was adjusted to 310 mOsm with NaCl, and the pH
adjusted to 7.4 with NaOH. The spiral ligament was isolated, and
the lateral wall of the cochlear second turn extracted. All
experiments were performed at 37uC using a temperature-control
chamber (Warner Instruments, Hamden, CT). Tissues were
maintained in the physiological solution until needed.
In Vivo Preparation
Guinea pigs were anesthetized with an injection of ketamine
(40 mg/kg) and xylazine (10 mg/kg), and wrapped in a heating
pad, with rectal temperature maintained at approximately 37uC.
The head was fastened in a heated manipulator to prevent
conductive cooling. The right jugular vein was cannulated for
injection of fluorescent dye, and the contralateral carotid artery
cannulated in a retrograde manner for continuous blood-pressure
measurement. The left bulla was opened through a lateral and
ventral approach, leaving the tympanic membrane and ossicles
intact. To observe blood circulation in vessels of the spiral
ligament, a rectangular fenestra (0.260.3 mm ‘‘vessel-window’’)
was made over the third turn by gently scoring and elevating the
cochlear bony wall with a small knife blade [22,23]. The vessel–
window was cover-slipped to preserve normal physiological
conditions and provide the best optical view for recording vessel
images (see Fig. S2). By adjusting the optical focus, the fibrocytes
and vessels of the spiral ligament were visualized. The vessels
located in the window were continuously monitored with video-
microscopy using a long working-distance objective lens (206,N A
0.4). The images were recorded with a CCD camera at a rate of 30
frames/sec and digitally saved to a computer disk.
Photolysis of Caged Calcium and Imaging of Calcium
Signals in Vitro and in Vivo
The cochlear capillaries were pre-labeled with the fluorescent
dye 1, 1-Dioctadecyl-3,3,3,3-tetramethylindocarbocyanine per-
chlorate, Dil [24] dissolved in DMSO (6 mg/ml). Immediately
prior to IV infusion, the stock solution was diluted with phosphate
buffered saline (PBS) to a final concentration of 3 mg/ml. One ml
of the dye solution was slowly administrated intravenously to the
guinea pig over a 5 min interval. For in vitro uncaging experiments,
isolated segments of the cochlear lateral wall were incubated in o-
nitrophenyl EGTA AM (a caged-Ca
2+ probe, 10 mM, Invitrogen),
pluronic acid (2.6 mg/ml), and fluo-4AM (10 mM, Invitrogen) for
30 min, and the tissues viewed with an FV1000 Olympus laser-
scanning confocal microscope and 406objective (NA 1.3). Fluo-4,
used as a sensor for intracellular Ca
2+, was excited at 488 nm and
its fluorescence acquired through a 510 nm emission filter. Ca
2+ in
fibrocytes was photo-released with 600 nanosecond flashes of
405 nm laser light focused to a 5 mm spot. For in vivo uncaging
experiments, the vessel-window was loaded with the same caged
Ca
2+ compound for 60 min. Intracellular Ca
2+ was imaged on an
Olympus BXFM fluorescence microscope equipped with a long-
working-distant objective (206, NA 0.4). Excitation at 375 nm, for
photolysis of the Ca
2+ cage, NP-EGTA, was obtained from a diode
laser light source focused to a 10 mm spot. Images were captured
by a Hamamatsu CCD camera, with the intracellular Ca
2+ signals
selected and analyzed on ImageJ software (NIH). The strength of
the Ca
2+ signal was assessed as a relative increase of fluorescence
from baseline intensity (DF/F).
Capillary Diameter and Blood Velocity Measurements
The internal (luminal) diameter of the capillaries was deter-
mined from acquired images as the distance between two fixed
points across the capillary and directly adjacent to an identified
fibrocyte end-foot using ImageJ [25]. Capillary diameter was
measured at locations of maximum response. Constriction or
dilation was presented either as a change in diameter or
percentage of the baseline diameter. Blood velocity was deter-
mined from captured video frames and analyzed off-line. Blood
flow velocity was calculated by a cross-correlation method using
custom-made image analysis software.
Sound Stimulation
A 500 Hz pure tone (a frequency optimal for the third turn
vessel window) was applied in the external ear canal. Sound was
administered at an intensity of 85 dB SPL. CBF was recorded for
3 min prior to sound stimulation, the last 3 minutes of the 10-min
duration of sound stimulation, and for 3 additional minutes with
the sound stimulation turned off. In the control group, the vessel-
window was superfused with a perilymphatic solution for 10 min
prior to sound stimulation and continued for the duration of the
stimulus. In the inhibitory group, the vessel-window was
superfused with a perilymphatic solution containing either the
COX-1 inhibitor SC 560 for 10 min or the gap junction blocker
CBX for 30 min by superfusion prior to sound stimulus and
continued throughout the stimulus. A flow chart of the
experimental sequence is shown in Fig. S3.
Transmission Electron Microscopy
Cochlear lateral wall tissues were dissected and fixed overnight
with phosphate buffered 3% glutaraldehyde-1.5% paraformalde-
hyde and postfixed in 1% osmium. Tissues were dehydrated and
embedded in Araldite plastic, sectioned, stained with lead citrate
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electron microscope.
Immunohistochemistry
The primary antibodies used in the experiments included anti-
desmin (rabbit monoclonal to desmin, cat# ab32362, Abcam,
Cambridge, MA), anti-collagen type IV (cat# ab6586, Abcam,
Cambridge, MA), anti-COX1 (cat# Sc-1752, Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA), anti-S100 (cat# ab8330, Abcam,
Cambridge, MA), and anti-Na
+/K
+ ATPase b1 (cat# 06-170,
Upstate, Lake Placid, NY).
Secondary antibodies (Invitrogen, Carlsbad, CA) included Alexa
fluor 568 conjugate goat-anti-rabbit (cat# A11011), Alexa fluor 488
conjugate goat anti-rabbit (1:100, cat# A11008, Invitrogen), Alexa
fluor 488 conjugate goat anti-mouse IgG (H+L) (1:100, cat#
A11001), and Alexa fluor 568 conjugate rabbit anti-goat (cat#
A11079).
Immunohistochemistry was performed as described previously
[26]. Briefly, tissue sections were permeabilized in 0.5% Triton X-
100 (Sigma, St. Louis, MO) for 1 h and immuno-blocked in a
solution of 10% goat serum and 1% bovine serum albumin (BSA)
in 0.02 M PBS for 1 h. The specimens were incubated overnight
at 4uC with the primary antibody diluted in PBS-BSA. After
several washes in PBS, the sections were incubated in a secondary
antibody for 1 h at room temperature. Finally, after washes in
PBS, the tissues were mounted with Slow Fade Light Antifade
reagent (Invitrogen) and visualized with an Olympus Fluoview
FV1000 confocal laser microscope system on an Olympus IX81
inverted frame. The controls were prepared by replacing primary
antibodies with 0.2% Triton X-100 in PBS.
Triple Labeling
To visualize the suprastrial structure of the cochlear-lateral wall,
we triple labeled lateral-wall tissues with an antibody for desmin
(or NG2) to identify pericytes (Abcam), isolectin GS-IB4 Alexa
Fluor 647 to identify vessels (Invitrogen), and phalloidin-
conjugated FITC to label the overall structure (Invitrogen). The
procedure for immunohistochemically labeled desmin was the
same as described above, except that 1:400 isolectin GS-IB4 was
added to the medium, along with the primary antibody for
desmin.
Double labeling
To visualize the spatial relationship between fibrocytes and
capillaries, the whole mounted cochlear lateral-wall tissue was
double labeled with an antibody for either S-100 or Na
+/K
+
ATPase b1 to identify the fibrocytes, and isolectin GS-IB4 Alexa
Fluor 647 to identify the vessels (Invitrogen).
Reverse Transcription Polymerase Chain Reaction
Total RNA from the cochlear lateral wall was separately
extracted for each experimental group with a RNeasy kit (Qiagen,
Valencia, CA) according to the manufacturer’s suggestions. Each
cohort of two mice was analyzed for COX mRNA. One mg of total
RNA was reverse-transcribed using a RETROscript kit (Ambion,
Austin, TX). Conserved regions spanning introns were selected for
the primers of Cox and glyceraldehyde-3-phosphate dehydroge-
nase (Gapdh). The primers used were: Cox1 (mouse Chr 2
NM_008969), forward; CATCCATCCACTCCCAGA, reverse;
GAGGGCTGGGGATAAGGTTGG; 409-bp product; Cox2
(mouse Chr 1 NM_011198), forward; GGGTTGCTGGGGGAA-
ATGTG, reverse; GGTGGCTGTTTTGGTAGGTG; 479-bp;
Cox3 (mouse Chr 2 NM_008969), forward; CAGAGTCATGAG-
TCGTGAG, reverse; AGAGGGCAGAATGCGAGTAT; 584-
bp; Gapdh (mouse Chr 6 NM_008084), forward; AACTTTGG-
CATTGTGGAAGG, reverse; ACACATTGGGGGTAGGAAC-
A; 272-bp product. The RT-PCR was cycled at 95uC for 2 min,
up to 40 cycles at 95uC for 30 sec, 60uC for 45 sec, 72uC for
30 sec, and a final 5-min extension at 72uC. The products of the
reverse transcription polymerase chain reaction were visualized by
agarose gel electrophoresis.
DAF-2DA staining for NO
NO production was detected with the fluorescent indicator,
diaminofluorescein – 2 diacetate (DAF-2DA), as previously
described [27]. The auditory bulla was dissected and rapidly
opened in a petri dish of physiological solution. Small pieces of
tissue from the basal middle turn of the cochlear-lateral wall were
removed, incubated in a physiological solution at 37uC, pH 7.4,
containing 10 mmol/L DAF-2DA (cat
# 251505, Calbiochem,
USA) for 30 min, and subsequently washed in fresh physiological
solution for 10 min and imaged by confocal microscopy.
COX Pathway Inhibition and Gap Junction Blockage
To determine whether the COX-1 pathway is involved in type
V fibrocyte-capillary coupled signaling, tissues were pretreated
with a specific COX-1 inhibitor, SC-560 [28,29,30]. To determine
whether gap junctions are involved in the sound-induced Ca
2+
signaling of fibrocytes, tissues were pretreated with a specific gap
junction blocker, carbenoxolone (CBX; at 100 mM) [31,32,33].
The COX-1 inhibitor was added to the perfusion bath 10 min
before photolysis and maintained in solution during photolysis.
The gap junction blocker, CBX, was added to the perfusion bath,
as well as directly applied to the round window, 30 min prior to
sound stimulation (see Fig. S3).
Measurement of COX-1 Enzymatic Activity
Anaesthetized animals were perfused with PBS to remove any
red blood cells and sacrificed. The cochleae were removed from
the auditory bullae immediately after sacrifice. Super-strial regions
of the lateral wall were carefully separated from the cochleae, and
the tissues incubated in a perilymphatic solution containing
different concentrations of SC 560 (10
27 M, 10
26 M, 10
25 M,
10
24 M, 10
23 M, 10
22 M) for 30 min. Tissues were homoge-
nized in 300 mL 0.1 M Tris-HCl buffer (pH 7.8) and centrifuged
at 10,000 g for 15 minutes at 4uC. COX-1 activity of the
supernatant was measured using a COX activity assay kit
(Cat#760151, Cayman Chemical, Ann Arbor, MI) in the
presence of a COX-2 inhibitor according to manufacturer’s
instructions.
Statistics
Data are presented as means 6 s.d. Statistical significance was
determined by using the Student’s t test (for two group comparisons)
or ANOVA (for three or more groups). A 95% confidence level was
considered statistically significant.
Results
Fibrocytes in the Super-strial Region Morphologically
Couple with Capillaries
Using confocal and transmission electron microscopy (TEM),
we found some fibrocytes in the supra-strial region have
interdigitating processes that abut the capillaries (Fig. 1). The
coupled fibrocytes expressed S-100 protein (Fig. 1A), a calcium
binding protein found in a wide range of mesenchymal cells,
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+/K
+-ATPaseb1
(Fig. 1B), a Na
+/K
+ pump that is also found in fibrocytes in other
regions of the spiral ligament (Suko et al., 2000). In addition, the
coupled fibrocytes exhibited significant nitric oxide (NO) produc-
tion (Fig. 1C). At high magnification, fibrocytes are seen connected
to microvessel walls through end-foot structures (Fig. 1D). Some
fibrocytes connected to capillaries through one or more processes
(Fig. 1E), while others directly connected to the body of pericytes
through their processes (Fig. 1F). Under TEM, fibrocytes
connected to capillaries were frequently found with enlarged
endings (Fig. 1G and 1H). They also appeared to directly connect
with capillaries through electron-dense membrane regions (Fig. 1I).
Ca
2+ Signaling between Fibrocytes and Capillaries
Photolytic release of Ca
2+ in stimulated fibrocytes in vitro evokes
a calcium signal which propagates to neighboring vascular cells,
including pericytes (PC) and endothelial cells (EC) positioned
along capillary walls. The high resolution confocal images in
Fig. 2A, imaged with DIC and fluorescence time-lapse, show Ca
2+
communication between stimulated fibrocytes and vascular cells.
Changes in fluorescence of the Ca
2+ probe in the stimulated
fibrocyte and, with delay, in the vascular cells are seen in the time
course image of Fig. 2B [movie S1].
Fibrocytes Regulate Capillary Diameter
An in vivo preparation of a vessel-window in the lateral wall was
used to test whether fibrocyte activation affects capillary diameter.
The vessel-window was made on the third turn of the cochlear
lateral wall in a live animal (see Fig. S2 for more details). Systemic
injection of the fluorescent dye Dil enabled visualization of the
capillaries. The spiral ligament in the vessel-window was
superfused with artificial perilymph and loaded with the Ca
2+
indicator probe fluo-4. An intravital microscope with a long
working distance objective enabled clear visualization of fluores-
cence in the fibrocytes. Fibrocytes with high intracellular calcium
signals from the supra-strial region of the spiral ligament were
Figure 1. Fibro-vascular coupled morphology under confocal and TEM microscopy. (A) Type V fibrocytes positive for S100 (green) abut
capillary walls labeled by isolectin IB4 (blue). (B) Type V fibrocytes are positive for Na
+/K
+ ATPase b1 (red). (C) Type V fibrocytes also contain high levels
of NO, as detected with the intracellular NO indicator, DAF-2DA (gray). (D) Magnification of panel B shows foot processes in contact with a capillary.
(E) A multiple-foot process of a fibrocyte abuts a capillary wall. (F) A high magnification image shows a fibrocyte end-foot structure at the soma of a
pericyte. The somas of the pericytes were labeled by an antibody for NG2, (red), and processes were labeled with an antibody for the structural
protein, desmin (blue).) Capillary walls are labeled by phalloidin (green). (G) and (H) Fibrocytes contact capillaries with enlarged endings. (I) The
endings display electron-dense membrane regions rich in mitochondria. Abbreviations: FC, fibrocyte; EC, endothelial cells; PC, pericyte; Mt,
mitochondria. Calibration bars in H and I are 500 nm.
doi:10.1371/journal.pone.0020652.g001
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higher intracellular fluo-4 fluorescence than other cells in the
cochlear lateral wall. The reason for this is unknown. Double
fluorescence immunohistochemical staining showed the high fluo-
4-AM fluorescent cells in the supra-strial region positive for S100,
a marker protein for fibrocytes, but negative for desmin, a pericyte
marker protein (see Fig. S4 and Fig. S5).
Ca
2+ was elevated by photolytically uncaging EGTA-AM with
UV excitation spatially targeted to 10 mm spots in the supra-strial
region. High Ca
2+ signaling in stimulated fibrocytes is associated
with dilation of vessels (Fig. 3 B and Fig. 3C). We found that
,53% of stimulated fibrocytes resulted in dilated vessels. When
dilation occurred, capillary diameter increased ,15% (Fig. 3C,
before: 9.1561.25 mm; after: 10.5561.36 mm, n=8, P,0.01).
COX-1 Metabolites Required for Vasodilation
We hypothesize that fibrocytes and vascular cells are coupled at
the fibro-vascular interface by local metabolic signals in vivo. The
COX signaling pathway for modulating capillary diameter was
specifically tested, as the pathway is known to be important in
regulating microvessel diameter in brain and retina [36,37]. Using
RT-PCR, we found mRNA for Cox-1 and Cox-3 expressed in the
cochlear lateral wall, with particularly high expression of COX-1
(Fig. 4A, left). Immunostaining revealed the COX-1 selectively
expressed in type V fibrocytes, but not in vascular cells (Fig. 4A,
right). The functional relevance of the signaling was tested by
inhibiting the COX-1 pathway. Photolysis of fibrocytes in a
‘‘vessel-window’’ superfused with perilymphatic solution was
associated with the dilation of vessels (Fig.4B). In contrast,
superfusion of the ‘‘vessel-window’’ with a perilymphatic solution
containing a specific inhibitor of COX-1, SC-560, at 500 mM for
10 min (applied concentrations were based on an in vitro dose-
response of COX-1 by SC-560, see Fig. S6) before photolysis
blocked photolysis-evoked vasodilation (Fig. 4C). Change in mean
capillary diameter was reduced (Fig. 4D, 2.2%61.1%, n=10,
P=0.11.0.05). The results link COX-1 to regulation of regional
blood flow.
Fibro-Vascular Coupled Mediation of Sound-induced CBF
Fibro-vascular units functionally ‘‘bridge’’ between increased
sound activity and CBF in vivo. In our model, fibro-vascular
coupled units integrate the mechanical energy of sound, initiate
Ca
2+ and COX-1 signaling, and affect CBF.
Sound stimulation applied to the inner ear causes Ca
2+ signaling
in fibrocytes. In these experiments blood flow was recorded of the
vessel-window preparation with a CCD camera for 3 min prior to
sound stimulation to establish a baseline, 10 min with sound
stimulation (500 Hz pure tone at 85 dB SPL applied to the external
ear), and for an additional 3 min following sound stimulation.
Tissues in the vessel-window were superfused with fluo 4, a Ca
2+
indicator, and intravenously pre-labeled with Dil. A flow chart of
the experimental sequence is provided in Fig. S3. Consistent with
previous reports [1], sound stimulation increased both blood flow
velocity (D velocity=22.7%, n=15, P,0.05, Fig. 5A) and capillary
diameter (D diameter=7.9%, n=15, P,0.05, Fig. 5B). In addition,
sound caused a significant increase in Ca
2+ signaling in fibrocytes
(Fig. 5C, middle). A plot of the normalized sound stimulated Ca
2+
indicator signal is shown in Fig. 5D.
Fibrocytes participate in ion transport and facilitate generation
of the EP by recycling K
+ from hair cells to intermediate cells in
the stria vascularis through gap junctions [13,18,19]. It follows that
increased hair-cell activity must be matched by increased fibrocyte
metabolism. Involvement of fibro-vascular coupled signaling was
tested by blocking the gap junctions between epithelial cells. In
support of our conjecture, pre-treatment of the cochlea with a
specific blocker (CBX applied at 100 mM to the round window for
30 min, combined with a superfusion of perilymphatic solution
containing CBX at 100 mM before and during sound stimulation)
blocked sound-evoked Ca
2+ signaling (Fig. 5D) and eliminated the
vasodilative response to sound (Fig. 5A and 5B).
Figure 2. Photolysis of caged Ca
2+ in fibrocytes initiates a propagating Ca
2 wave in capillaries. (A) Fibrocytes communicate with nearby
vascular cells. The fibrocyte was stimulated by photolysis at 1 (the purple arrow indicates the site of the uncaging flash). Note the photolysis-evoked
Ca
2+ wave (1 FC) propagates sequentially to vascular cells [2 (PC), 3 (PC), 4 (PC), and 5 (EC)]. (B)C a
2+ probe fluorescence from stimulation of fibrocytes
propagates with delay to vascular cells.
doi:10.1371/journal.pone.0020652.g002
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sound induced capillary dilation. Superfusion of the vessel-
window with a perilymphatic solution containing a specific
inhibitor of COX-1, SC-560, at 100 mM and 500 mM for 10 min
before sound stimulation abolished sound-induced vessel dilation
and eliminates changes in blood flow velocity (Fig. 5A and 5B).
The result is consistent with results obtained from photolysis of
caged Ca
2+ (Fig. 4D).
The experimental findings support a model in which acoustic
stimulation elevates fibrocyte Ca
2+, initiates fibrocyte-to-fibrocyte
signaling, induces release of vasoactive compounds, and causes
vessel dilation.
Discussion
This study provides the first evidence that cochlear fibrocytes,
‘‘activated’’ by sound, mediate control of capillary diameter and
blood flow in the inner ear. The evidence suggests fibrocyte to
vascular cell signaling is a key mechanism modulating CBF in
response to sound.
Fibrocytes have long been regarded as simple supporting
cells; however, recent evidence suggests fibrocytes have other
functional roles under both physiological and pathological
conditions [15,38,39,40,41,42,43,44,45,46,47]. For example,
fibrocytes participate in ion transport, facilitating generation of
the endocochlear potential by recycling K
+ from hair cell
transduction.
Fibrocytes in the cochlear lateral wall are classified as types I to
V based on morphological appearance, staining pattern, and
general location [15,16] (also see Fig. S1). In general, type I
fibrocytes lie behind the stria vascularis and follow the curvature of
the lateral wall, while type II fibrocytes lie toward the scala
tympani side of the stria vascularis, and type III fibrocytes
circumferentially line the otic capsule. Type IV fibrocytes are
spindle-shaped and lateral to the basilar membrane, while type V
fibrocytes lie above the stria vascularis (supra-strial area) where
arterioles branch into precapillaries and into the two true capillary
networks, the capillaries of the spiral ligament and stria vascularis
[10]. In the supra-strial region pre-capillaries contain a high
population of pericytes. Pericytes on pre-capillaries are spaced
approximately 2–25 mm apart, compared to up to 100 mm on true
capillaries [8]. Pericyte contraction and dilation can significantly
affect capillary diameter [9,48]. Pericyte contraction would
significantly affect the flow resistance of the vascular network,
and profoundly impact overall blood flow.
In this study, we classified these capillary-coupled cells as
fibrocytes, based on the fibrocyte identification described by Spicer
and Schulte [15] as being immunohistochemically positive for S-
Figure 3. Photolysis of caged Ca
2+ in fibrocytes evokes vasodilation in vivo. ((A) Photolysis-evoked vasodilation (left, before photolysis; right,
after photolysis; white dotted lines in A, B indicate sites of dilation). (B) Photolysis-evoked, time-dependent change in intracellular Ca
2+ in stimulated
fibrocyte (green line) correlates with the change in capillary diameter (red line). (C) Mean fluorescent signal of the Ca
2+ indicator is significantly
increased. (D) Mean capillary diameter is significantly increased (n=8, P,0.01).
doi:10.1371/journal.pone.0020652.g003
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+/K
+-ATPaseb1 proteins, and exclusive of macro-
phages and pericytes (Fig. S1). However, this identification does
not conclusively exclude other cell types, as the complexity of the
lateral wall and lack of specific markers differentiating between
fibrocytes and other cell types of the same lineage make definitive
classification difficult.
In addition to expressing S-100 and Na
+/K
+-ATPaseb1
proteins, we found the connected fibrocytes display higher fluo-4
indicator fluorescence than other cells in the cochlear lateral wall
under in vivo conditions (see Fig. S4). A majority of the high fluo-4
fluorescence cells were S-100 positive. In our in vivo photolysis
study, high fluo-4 fluorescence was used to identify coupled
fibrocytes.
Changes in capillary diameter may directly result from pericyte
action (relaxation or contraction) or indirectly result from action
mediated by endothelial cells. In the case of indirect action,
endothelial cells would release vasodilatory factors, such as
endothelium-derived relaxing factor, to activate pericytes. In our
study, we found approximately half of in vivo stimulated fibrocytes
to dilate vessels. When dilation occurred, capillary diameter
increased ,15%. In contrast, only very occasional vasocontraction
was seen in stimulated in vitro preparations. In addition,
propagation of the Ca
2+ signal between stimulated fibrocyte and
vascular cells had a slightly longer latency period in vitro than in
vivo. The discrepancy in vasomotor response could have been the
result of experimental conditions, as vessels in the in vitro
preparation lack the influence of intravascular pressure and flow.
Also, in vitro vessel preparations usually do not develop
spontaneous tone, and relaxation responses can only be studied
after capillary preconstruction [49]. However, despite the lack of
contraction, Ca
2+ signaling between fibrocytes and capillaries was
still clearly observed in vitro (see Movie S1). Sound-initiated
changes in Ca
2+ signaling in fibrocytes underlie the functional
interaction between fibrocytes and vascular cells. The gating
mechanisms for the signaling are not clear, but both mechanical
stretch and metabolite effects may be involved. The metabolic
gating could also relate to the energy expenditure required for K
+
recycling, as blockage of gap junctions eliminates normal sound-
induced vasodilation. A working model is illustrated in Fig. 6
COX-1 activity is central to fibro-vascular coupled signaling in
the cochlea, as pre-incubation with a selective COX-1 inhibitor,
SC-560, blocks both photolytically released Ca
2+ and sound
induced vessel dilation in the cochlea in vivo. COX-1 activation
may be analogous to COX -dependent vascular regulation in
brain [50]. COX-1 is a rate-limiting enzyme which converts
arachidonic acid into prostaglandins [30]. Elevation of Ca
2+
increases COX activity and mobilizes arachidonic acid. COX
then converts arachidonic acid to a prostaglandin such as PGE2
Figure 4. Photolysis of caged Ca
2+ in fibrocytes evokes vasodiation in vivo through (A) mRNA for Cox-1 and Cox-3 is
expressed in the cochlear lateral wall (left). COX-1 protein is selectively expressed in type V fibrocytes, but not in vascular cells (right). (B) Photolysis
evokes vasodilation (left, before photolysis; right, after photolysis; white dotted lines in left, right indicates sites of dilation). (C) Lack of photolysis-
evoked vasodilation is shown (left, before photolysis; right, after photolysis; white dotted lines in left, right indicates sites of changes of capillary
diameter). (D) Mean capillary diameter is significantly increased before and after photolysis (n=8, P,0.01). In contrast, mean capillary diameter is
unchanged in tissues treated with a COX-1 inhibitor (n=10, P.0.05).
doi:10.1371/journal.pone.0020652.g004
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PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e20652[51]. Blocking the COX pathway is shown to deregulate
vasoactivity in several organ systems [52,53]. However, more
direct evidence on COX-1 metabolites is needed before firm
conclusions can be drawn. Nevertheless, the COX-1 product
involved in regional CBF regulation is a result consistent with the
results of others.
No significant capillary diameter and blood flow velocity
reduction was found after SC-560 administration in the control,
no-sound condition (see Figure 5). Fibrocytes, including type V
fibrocytes, participate in ion transport, which is essential for
generating the endocochlear potential required for hearing.
Increases in hair cell activity must be accompanied by increases
in fibrocyte metabolism, as fibrocytes are involved in dynamic K
+
recycling and in maintaining the endolymphatic potential needed
for hair cell sensitivity. Overall, our data indicate that COX-1
activity is the link between metabolic need and local blood flow.
In summary, regulation of blood flow in response to acoustic
activity is complex, since local processes controlling capillary flow
interact with central control exerted through direct innervation of
upstream vessels. There’s also evidence multiple metabolic
factors, including ATP, NO, and K
+, mediate CBF, as fibrocytes
produce NO and express both S-100, a Ca
2+-binding protein,
and Na
+/K
+-ATPase b1. Despite these complicating other
factors, however, this study establishes for the first time a
physiological link between fibrocytes and cochlear vessels which
underlies the response to sound. We were able to elucidate the
role of fibrocytes in controlling local blood flow experimentally by
using targeted in vivo and in vitro stimulation. We showed that
flow-metabolic coupled signaling is a key mechanism in
modulating CBF to meet the metabolic demand that results
from transduction of sound.
Supporting Information
Figure S1 Cochlear lateral wall structure from confocal
fluorescence images of the suprastrial region. (A) The
drawing shows the location of type I–V fibrocytes in the cochlear
lateral wall. (B) shows the organization of the suprastrial region.
Tissue was labeled with phalloidin for F-actin (green). The region
is rich in type V fibrocytes, pre-capillaries, and capillaries. (C)i sa n
image of pre-capillaries and capillaries labeled with isolection IB4.
(D) shows pericytes on the pre-capillaries and capillaries of the
spiral ligament which have been labeled with an antibody for
desmin, a marker for pericytes (red). (E) is a merged image from
Panels A, B, & C which shows the supra stria vascularis region
composed of pericyte-containing pre-capillaries, capillaries, and
surrounding fibrocytes. (The white line indicates the location of
Reissner’s membrane, while the area below and to the right of the
line is the suprastrial region.) Calibration bar with ticks is 50 mm.
(TIF)
Figure S2 Illustration of the vessel-window perfusion
system. Fluids are delivered under the coverslip by a microtube
connected to a manifold. This allows selection of the solution to be
perfused without any delay for clearance of tubing. Perfusion is
accomplished with a syringe pump. Fluid is wicked away from the
cochlea with cotton.
(TIF)
Figure S3 Flow chart of the experimental sequence.
(TIF)
Figure S4 Fluo-4 fluourescence in cells of the lateral
wall. Fibrocytes within a vessel-window of the super-strial region
displayed a higher intracellular signal of the fluorescent Ca
2+
indicator fluo-4 than other cells in the cochlear lateral wall.
Capillaries were labeled with the fluorescent dye Dil.
(TIF)
Figure S5 High fluo-4 fluorescence cells are fibrocytes.
Spiral ligament tissue in the vessel-window triple labeled with fluo-
4 (green), S-100 antibody (red), and desmin antibody (blue) verifies
a majority of high fluo-4-fluorescence cells (A, green) were positive
for S-100, a fibrocyte marker protein (B), but negative for desmin,
a pericyte marker protein (C). (D) A merged image from Panels A ,
B, and C. (E) A DIC image shows the capillaries located in the
Figure 5. Sound-induced changes of intracellular Ca
2+ in fibrocytes, blood-flow velocity, and capillary diameter. (A) and (B) Changes in
cochlear blood flow velocity and capillary diameter under a variety of conditions: control, sound stimulated, COX-1 inhibited, and sound stimulated
with COX-1 and CBX inhibition. Sound stimulation alone caused significant increases in capillary diameter and blood-flow velocity (n=15, P,0.05).
However, prior perfusion of the vessel-window with the COX-1-specific inhibitor, SC 560, or with the gap junction blocker, CBX , essentially blocked
the sound-induced dilation. The cartoon shows the sound-stimulation protocol. (C) Intracellular Ca
2+ signals are shown under control (left, no sound)
and sound-stimulated conditions (middle, sound on). Fluorescence of the intracellular Ca
2+ probe in some fibrocytes (arrows) returns to normal about
2 min after sound stimulation (right, sound off). (D) Mean Ca
2+ signal was significantly higher in the sound stimulated fibrocytes.
doi:10.1371/journal.pone.0020652.g005
Figure 6. A working model of fibro-vascular coupled signaling
in the inner ear. The schematic diagram illustrates selected aspects of
fibrocyte signaling. Sound stimulation (red dotted line) activates hair
cells and initiates Ca
2+ signaling in fibrocytes. While the gating
mechanisms for the Ca
2+ signaling have not been determined,
mechanical vibration or metabolic activity, such as K
+ recycling,
initiated by sound might underlie the gating. COX-1 is regulated by
the elevation of Ca
2+ in fibrocytes. The COX-1 converts arachidonic acid
into metabolic intermediates, including PGE2, which diffuse into the
perivascular space to elicit vasodilatation.
doi:10.1371/journal.pone.0020652.g006
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E.
(TIF)
Figure S6 (A) shows the dose-dependent inhibition of COX-1 by
SC560 (data are expressed as mean 6 SEM, n=3 for each
treatment). The IC50 for SC-560 in cochlear tissue is about 1 mM.
Complete inhibition occurred at a concentration of ,100 mM.
(B & C) show the effect of different concentrations of SC-560 on
blood flow velocity and capillary diameter.
(TIF)
Movie S1 Photolysis-evoked Ca
2+ signaling between
fibrocytes and vascular cells. The photolysis-evoked Ca
2+
wave (1 FC) propagates sequentially to vascular cells [2 (PC), 3 (PC), 4
(PC), and 5 (EC). UV light stimulation is indicated by the purple arrow.
(AVI)
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